Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)

China flag China · Delayed Price · Currency is CNY
11.19
+0.21 (1.91%)
Mar 10, 2026, 3:04 PM CST
60.78%
Market Cap 6.30B
Revenue (ttm) 1.13B
Net Income (ttm) 33.43M
Shares Out 562.87M
EPS (ttm) 0.07
PE Ratio 156.56
Forward PE n/a
Dividend 0.05 (0.46%)
Ex-Dividend Date n/a
Volume 45,155,438
Average Volume 40,656,392
Open 10.03
Previous Close 10.98
Day's Range 10.03 - 11.31
52-Week Range 5.42 - 11.98
Beta 0.52
RSI 66.03
Earnings Date Apr 22, 2026

About SHE:300016

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as wel... [Read more]

Sector Healthcare
Founded 1992
Employees 1,173
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300016
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.